✦ LIBER ✦

A phase II study of cisplatin (P)and low dose continous oral etoposide (V) in advanced non small cell lung cancer (NSCLC)

✍ Scribed by Alvarez, I.; Sénchez, M.; Paredes, A.; Piara, J.; Abed, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Phase II trial with weekly cisplatin (CD

✍ Lopez, R.; Fernandez, R.; Virizuela, J.A.; Cueva, J.; Garcia, E.; Sanz, A.; Vale 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A phase II study of weekly high-dose cis

✍ André Planting; Siang Kho; Maria van der Burg; H. Goey; J. Schellens; Martin van 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 107 KB

53 P - Ifosfamide, cisplatin and etoposi

✍ A.F. Scinto; M. Milella; E.A. Rendina; R. Tonachella; M. Nardi; E. Tucci; C. San 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Clinical and pharmacological phase II st

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase II study of prolonged oral etoposi

✍ Miller, Antonius A.; Niell, Harvey B.; Griffin, John P. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 473 KB